Polygiene Group AB

Based in Malmö, Sweden, and founded in 2005, Polygiene Group AB develops, produces, and markets advanced solutions designed to control odors and maintain freshness across a wide range of materials. These applications extend to clothing, athletic equipment, various textiles, and other products. The company's operations span globally, serving markets throughout the Middle East, Africa, the Asia Pacific region, the Americas, and Europe. Polygiene caters to a diverse portfolio of partners across sectors including sports and outdoor activities, fashion and lifestyle, industrial uses, workwear, hospitality, household items, pet care, healthcare, water management, and paper and packaging. Its entire product line is offered under the Polygiene brand. The company officially changed its name to Polygiene Group AB in June 2022, having previously operated as Polygiene AB (publ.).

Polygiene Group AB trades as POLYG.ST on STO. The company is classified in Basic Materials / Chemicals - Specialty and reports in SEK.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Polygiene Group AB can be compared against peers such as Svenska Aerogel Holding AB (publ), Arctic Minerals AB (publ), aXichem AB, BE Group AB (publ), Nexam Chemical Holding AB (publ), Nordic Iron Ore AB (publ).

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $205.28M, beta of 1.58, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

POLYG.ST currently shows total debt of N/A and beta of 1.58. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.polygiene.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.